- Home
- HRTX vs WALD Comparison
HRTX vs WALD Comparison
Compare HRTX & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- WALD
- Stock Information
- Founded
- HRTX 1983
- WALD 1988
- Country
- HRTX United States
- WALD United States
- Employees
- HRTX N/A
- WALD N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- WALD Package Goods/Cosmetics
- Sector
- HRTX Health Care
- WALD Consumer Discretionary
- Exchange
- HRTX Nasdaq
- WALD Nasdaq
- Market Cap
- HRTX 325.0M
- WALD 291.5M
- IPO Year
- HRTX 1987
- WALD 2021
- Fundamental
- Price
- HRTX $1.98
- WALD $2.25
- Analyst Decision
- HRTX Strong Buy
- WALD Strong Buy
- Analyst Count
- HRTX 2
- WALD 5
- Target Price
- HRTX $5.00
- WALD $5.16
- AVG Volume (30 Days)
- HRTX 1.1M
- WALD 123.4K
- Earning Date
- HRTX 08-05-2025
- WALD 07-01-2025
- Dividend Yield
- HRTX N/A
- WALD N/A
- EPS Growth
- HRTX N/A
- WALD N/A
- EPS
- HRTX N/A
- WALD N/A
- Revenue
- HRTX $148,518,000.00
- WALD $273,868,000.00
- Revenue This Year
- HRTX $12.08
- WALD $14.78
- Revenue Next Year
- HRTX $12.57
- WALD $15.84
- P/E Ratio
- HRTX N/A
- WALD N/A
- Revenue Growth
- HRTX 12.43
- WALD 25.55
- 52 Week Low
- HRTX $1.04
- WALD $1.98
- 52 Week High
- HRTX $3.73
- WALD $4.74
- Technical
- Relative Strength Index (RSI)
- HRTX 49.25
- WALD 42.65
- Support Level
- HRTX $1.90
- WALD $2.09
- Resistance Level
- HRTX $2.07
- WALD $2.50
- Average True Range (ATR)
- HRTX 0.10
- WALD 0.16
- MACD
- HRTX 0.00
- WALD -0.01
- Stochastic Oscillator
- HRTX 32.81
- WALD 25.58
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.